S. Cholerton
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
- Pharmacology 17
- Pharmacogenetics and Drug Metabolism 16
-
- Glutathione Transferases and Polymorphisms 7
- Co-authors
- Jeffrey R. Idle (19 shared papers)Ann K. Daly (12 shared papers)Melissa J. Armstrong (2 shared papers)AM Breckenridge (5 shared papers)D. Nicholas Bateman (2 shared papers)BP Haynes (4 shared papers)W. Larry Gregory (2 shared papers)William E. Evans (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (7 papers)Archives of Toxicology (2 papers)Human & Experimental Toxicology (2 papers)The Lancet (1 paper)QJM (1 paper)
- Partner nations
- United KingdomTürkiyeJordan
In The Last Decade
S. Cholerton
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Pharmacology 889
- Cancer Research 232
- Biochemistry 106
- Oncology 339
- Internal Medicine 35
Countries citing papers authored by S. Cholerton
This map shows the geographic impact of S. Cholerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cholerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cholerton more than expected).
Fields of papers citing papers by S. Cholerton
This network shows the impact of papers produced by S. Cholerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cholerton. The network helps show where S. Cholerton may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Cholerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. | 1995 | 258 |
| 2 | 1992 | 212 | |
| 3 | 1992 | 186 | |
| 4 | 1993 | 138 | |
| 5 | 1994 | 105 | |
| 6 | 1997 | 83 | |
| 7 | 1994 | 77 | |
| 8 | 2002 | 76 | |
| 9 | 1986 | 75 | |
| 10 | 1988 | 73 | |
| 11 | 1992 | 71 | |
| 12 | 1998 | 60 | |
| 13 | 1996 | 53 | |
| 14 | 1992 | 53 | |
| 15 | 1986 | 51 | |
| 16 | A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit. | 1985 | 50 |
| 17 | 1986 | 47 | |
| 18 | 1998 | 37 | |
| 19 | 1990 | 37 | |
| 20 | 2004 | 34 |
About S. Cholerton
S. Cholerton is a scholar working on Pharmacology, Molecular Biology, Nutrition and Dietetics, Biochemistry and Pediatrics, Perinatology and Child Health, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Glutathione Transferases and Polymorphisms (7 papers), Vitamin K Research Studies (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Carcinogens and Genotoxicity Assessment (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Epilepsy research and treatment (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (889 citations), Cancer Research (232 citations), Biochemistry (106 citations), Oncology (339 citations) and Internal Medicine (35 citations). S. Cholerton has collaborated with scholars based in United Kingdom, Türkiye and Jordan. Frequent co-authors include Jeffrey R. Idle, Ann K. Daly, Melissa J. Armstrong, AM Breckenridge, D. Nicholas Bateman, BP Haynes, W. Larry Gregory, William E. Evans, K. Zahlsen and Susan M.G. Hoffman. Their work appears in journals such as British Journal of Clinical Pharmacology, Archives of Toxicology, Human & Experimental Toxicology, The Lancet and QJM.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.